Global Neisseria meningitidis Infections Drug Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Neisseria meningitidis Infections Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neisseria meningitidis Infections Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neisseria meningitidis Infections Drug market in any manner.
Global Neisseria meningitidis Infections Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Market Segmentation (by Type)
MGBBP-3
NCL-195
TP-10
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neisseria meningitidis Infections Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Neisseria meningitidis Infections Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neisseria meningitidis Infections Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neisseria meningitidis Infections Drug market in any manner.
Global Neisseria meningitidis Infections Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Market Segmentation (by Type)
MGBBP-3
NCL-195
TP-10
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neisseria meningitidis Infections Drug Market
- Overview of the regional outlook of the Neisseria meningitidis Infections Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neisseria meningitidis Infections Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neisseria meningitidis Infections Drug
1.2 Key Market Segments
1.2.1 Neisseria meningitidis Infections Drug Segment by Type
1.2.2 Neisseria meningitidis Infections Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neisseria meningitidis Infections Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neisseria meningitidis Infections Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Neisseria meningitidis Infections Drug Sales by Manufacturers (2019-2024)
3.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neisseria meningitidis Infections Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neisseria meningitidis Infections Drug Sales Sites, Area Served, Product Type
3.6 Neisseria meningitidis Infections Drug Market Competitive Situation and Trends
3.6.1 Neisseria meningitidis Infections Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neisseria meningitidis Infections Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEISSERIA MENINGITIDIS INFECTIONS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Neisseria meningitidis Infections Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2019-2024)
6.3 Global Neisseria meningitidis Infections Drug Market Size Market Share by Type (2019-2024)
6.4 Global Neisseria meningitidis Infections Drug Price by Type (2019-2024)
7 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neisseria meningitidis Infections Drug Market Sales by Application (2019-2024)
7.3 Global Neisseria meningitidis Infections Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Neisseria meningitidis Infections Drug Sales Growth Rate by Application (2019-2024)
8 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY REGION
8.1 Global Neisseria meningitidis Infections Drug Sales by Region
8.1.1 Global Neisseria meningitidis Infections Drug Sales by Region
8.1.2 Global Neisseria meningitidis Infections Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Neisseria meningitidis Infections Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neisseria meningitidis Infections Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neisseria meningitidis Infections Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neisseria meningitidis Infections Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neisseria meningitidis Infections Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Beijing Minhai Biotechnology Co Ltd
9.1.1 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Basic Information
9.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Overview
9.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.1.4 Beijing Minhai Biotechnology Co Ltd Business Overview
9.1.5 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug SWOT Analysis
9.1.6 Beijing Minhai Biotechnology Co Ltd Recent Developments
9.2 Biological E Ltd
9.2.1 Biological E Ltd Neisseria meningitidis Infections Drug Basic Information
9.2.2 Biological E Ltd Neisseria meningitidis Infections Drug Product Overview
9.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.2.4 Biological E Ltd Business Overview
9.2.5 Biological E Ltd Neisseria meningitidis Infections Drug SWOT Analysis
9.2.6 Biological E Ltd Recent Developments
9.3 China National Pharmaceutical Group Corp
9.3.1 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Basic Information
9.3.2 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Overview
9.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Market Performance
9.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug SWOT Analysis
9.3.5 China National Pharmaceutical Group Corp Business Overview
9.3.6 China National Pharmaceutical Group Corp Recent Developments
9.4 GlaxoSmithKline Plc
9.4.1 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Basic Information
9.4.2 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Overview
9.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Market Performance
9.4.4 GlaxoSmithKline Plc Business Overview
9.4.5 GlaxoSmithKline Plc Recent Developments
9.5 Griffith University
9.5.1 Griffith University Neisseria meningitidis Infections Drug Basic Information
9.5.2 Griffith University Neisseria meningitidis Infections Drug Product Overview
9.5.3 Griffith University Neisseria meningitidis Infections Drug Product Market Performance
9.5.4 Griffith University Business Overview
9.5.5 Griffith University Recent Developments
9.6 ImmunoBiology Ltd
9.6.1 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Basic Information
9.6.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Overview
9.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.6.4 ImmunoBiology Ltd Business Overview
9.6.5 ImmunoBiology Ltd Recent Developments
9.7 JN-International Medical Corp
9.7.1 JN-International Medical Corp Neisseria meningitidis Infections Drug Basic Information
9.7.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Overview
9.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Market Performance
9.7.4 JN-International Medical Corp Business Overview
9.7.5 JN-International Medical Corp Recent Developments
9.8 MGB Biopharma Ltd
9.8.1 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Basic Information
9.8.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Overview
9.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.8.4 MGB Biopharma Ltd Business Overview
9.8.5 MGB Biopharma Ltd Recent Developments
9.9 Panacea Biotec Ltd
9.9.1 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Basic Information
9.9.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Overview
9.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.9.4 Panacea Biotec Ltd Business Overview
9.9.5 Panacea Biotec Ltd Recent Developments
9.10 Pfizer Inc
9.10.1 Pfizer Inc Neisseria meningitidis Infections Drug Basic Information
9.10.2 Pfizer Inc Neisseria meningitidis Infections Drug Product Overview
9.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Product Market Performance
9.10.4 Pfizer Inc Business Overview
9.10.5 Pfizer Inc Recent Developments
9.11 Sanofi Pasteur SA
9.11.1 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Basic Information
9.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Overview
9.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Market Performance
9.11.4 Sanofi Pasteur SA Business Overview
9.11.5 Sanofi Pasteur SA Recent Developments
9.12 Serum Institute of India Ltd
9.12.1 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Basic Information
9.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Overview
9.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.12.4 Serum Institute of India Ltd Business Overview
9.12.5 Serum Institute of India Ltd Recent Developments
9.13 Wellstat Vaccines LLC
9.13.1 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Basic Information
9.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Overview
9.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Market Performance
9.13.4 Wellstat Vaccines LLC Business Overview
9.13.5 Wellstat Vaccines LLC Recent Developments
10 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET FORECAST BY REGION
10.1 Global Neisseria meningitidis Infections Drug Market Size Forecast
10.2 Global Neisseria meningitidis Infections Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neisseria meningitidis Infections Drug Market Size Forecast by Country
10.2.3 Asia Pacific Neisseria meningitidis Infections Drug Market Size Forecast by Region
10.2.4 South America Neisseria meningitidis Infections Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neisseria meningitidis Infections Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neisseria meningitidis Infections Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neisseria meningitidis Infections Drug by Type (2025-2030)
11.1.2 Global Neisseria meningitidis Infections Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neisseria meningitidis Infections Drug by Type (2025-2030)
11.2 Global Neisseria meningitidis Infections Drug Market Forecast by Application (2025-2030)
11.2.1 Global Neisseria meningitidis Infections Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Neisseria meningitidis Infections Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neisseria meningitidis Infections Drug
1.2 Key Market Segments
1.2.1 Neisseria meningitidis Infections Drug Segment by Type
1.2.2 Neisseria meningitidis Infections Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neisseria meningitidis Infections Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neisseria meningitidis Infections Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Neisseria meningitidis Infections Drug Sales by Manufacturers (2019-2024)
3.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neisseria meningitidis Infections Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neisseria meningitidis Infections Drug Sales Sites, Area Served, Product Type
3.6 Neisseria meningitidis Infections Drug Market Competitive Situation and Trends
3.6.1 Neisseria meningitidis Infections Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neisseria meningitidis Infections Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEISSERIA MENINGITIDIS INFECTIONS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Neisseria meningitidis Infections Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2019-2024)
6.3 Global Neisseria meningitidis Infections Drug Market Size Market Share by Type (2019-2024)
6.4 Global Neisseria meningitidis Infections Drug Price by Type (2019-2024)
7 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neisseria meningitidis Infections Drug Market Sales by Application (2019-2024)
7.3 Global Neisseria meningitidis Infections Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Neisseria meningitidis Infections Drug Sales Growth Rate by Application (2019-2024)
8 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY REGION
8.1 Global Neisseria meningitidis Infections Drug Sales by Region
8.1.1 Global Neisseria meningitidis Infections Drug Sales by Region
8.1.2 Global Neisseria meningitidis Infections Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Neisseria meningitidis Infections Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neisseria meningitidis Infections Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neisseria meningitidis Infections Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neisseria meningitidis Infections Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neisseria meningitidis Infections Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Beijing Minhai Biotechnology Co Ltd
9.1.1 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Basic Information
9.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Overview
9.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.1.4 Beijing Minhai Biotechnology Co Ltd Business Overview
9.1.5 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug SWOT Analysis
9.1.6 Beijing Minhai Biotechnology Co Ltd Recent Developments
9.2 Biological E Ltd
9.2.1 Biological E Ltd Neisseria meningitidis Infections Drug Basic Information
9.2.2 Biological E Ltd Neisseria meningitidis Infections Drug Product Overview
9.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.2.4 Biological E Ltd Business Overview
9.2.5 Biological E Ltd Neisseria meningitidis Infections Drug SWOT Analysis
9.2.6 Biological E Ltd Recent Developments
9.3 China National Pharmaceutical Group Corp
9.3.1 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Basic Information
9.3.2 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Overview
9.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Market Performance
9.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug SWOT Analysis
9.3.5 China National Pharmaceutical Group Corp Business Overview
9.3.6 China National Pharmaceutical Group Corp Recent Developments
9.4 GlaxoSmithKline Plc
9.4.1 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Basic Information
9.4.2 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Overview
9.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Market Performance
9.4.4 GlaxoSmithKline Plc Business Overview
9.4.5 GlaxoSmithKline Plc Recent Developments
9.5 Griffith University
9.5.1 Griffith University Neisseria meningitidis Infections Drug Basic Information
9.5.2 Griffith University Neisseria meningitidis Infections Drug Product Overview
9.5.3 Griffith University Neisseria meningitidis Infections Drug Product Market Performance
9.5.4 Griffith University Business Overview
9.5.5 Griffith University Recent Developments
9.6 ImmunoBiology Ltd
9.6.1 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Basic Information
9.6.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Overview
9.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.6.4 ImmunoBiology Ltd Business Overview
9.6.5 ImmunoBiology Ltd Recent Developments
9.7 JN-International Medical Corp
9.7.1 JN-International Medical Corp Neisseria meningitidis Infections Drug Basic Information
9.7.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Overview
9.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Market Performance
9.7.4 JN-International Medical Corp Business Overview
9.7.5 JN-International Medical Corp Recent Developments
9.8 MGB Biopharma Ltd
9.8.1 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Basic Information
9.8.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Overview
9.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.8.4 MGB Biopharma Ltd Business Overview
9.8.5 MGB Biopharma Ltd Recent Developments
9.9 Panacea Biotec Ltd
9.9.1 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Basic Information
9.9.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Overview
9.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.9.4 Panacea Biotec Ltd Business Overview
9.9.5 Panacea Biotec Ltd Recent Developments
9.10 Pfizer Inc
9.10.1 Pfizer Inc Neisseria meningitidis Infections Drug Basic Information
9.10.2 Pfizer Inc Neisseria meningitidis Infections Drug Product Overview
9.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Product Market Performance
9.10.4 Pfizer Inc Business Overview
9.10.5 Pfizer Inc Recent Developments
9.11 Sanofi Pasteur SA
9.11.1 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Basic Information
9.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Overview
9.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Market Performance
9.11.4 Sanofi Pasteur SA Business Overview
9.11.5 Sanofi Pasteur SA Recent Developments
9.12 Serum Institute of India Ltd
9.12.1 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Basic Information
9.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Overview
9.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Market Performance
9.12.4 Serum Institute of India Ltd Business Overview
9.12.5 Serum Institute of India Ltd Recent Developments
9.13 Wellstat Vaccines LLC
9.13.1 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Basic Information
9.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Overview
9.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Market Performance
9.13.4 Wellstat Vaccines LLC Business Overview
9.13.5 Wellstat Vaccines LLC Recent Developments
10 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET FORECAST BY REGION
10.1 Global Neisseria meningitidis Infections Drug Market Size Forecast
10.2 Global Neisseria meningitidis Infections Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neisseria meningitidis Infections Drug Market Size Forecast by Country
10.2.3 Asia Pacific Neisseria meningitidis Infections Drug Market Size Forecast by Region
10.2.4 South America Neisseria meningitidis Infections Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neisseria meningitidis Infections Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neisseria meningitidis Infections Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neisseria meningitidis Infections Drug by Type (2025-2030)
11.1.2 Global Neisseria meningitidis Infections Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neisseria meningitidis Infections Drug by Type (2025-2030)
11.2 Global Neisseria meningitidis Infections Drug Market Forecast by Application (2025-2030)
11.2.1 Global Neisseria meningitidis Infections Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Neisseria meningitidis Infections Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neisseria meningitidis Infections Drug Market Size Comparison by Region (M USD)
Table 5. Global Neisseria meningitidis Infections Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neisseria meningitidis Infections Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neisseria meningitidis Infections Drug as of 2022)
Table 10. Global Market Neisseria meningitidis Infections Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neisseria meningitidis Infections Drug Sales Sites and Area Served
Table 12. Manufacturers Neisseria meningitidis Infections Drug Product Type
Table 13. Global Neisseria meningitidis Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neisseria meningitidis Infections Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neisseria meningitidis Infections Drug Market Challenges
Table 22. Global Neisseria meningitidis Infections Drug Sales by Type (Kilotons)
Table 23. Global Neisseria meningitidis Infections Drug Market Size by Type (M USD)
Table 24. Global Neisseria meningitidis Infections Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2019-2024)
Table 26. Global Neisseria meningitidis Infections Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Neisseria meningitidis Infections Drug Market Size Share by Type (2019-2024)
Table 28. Global Neisseria meningitidis Infections Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neisseria meningitidis Infections Drug Sales (Kilotons) by Application
Table 30. Global Neisseria meningitidis Infections Drug Market Size by Application
Table 31. Global Neisseria meningitidis Infections Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2019-2024)
Table 33. Global Neisseria meningitidis Infections Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Neisseria meningitidis Infections Drug Market Share by Application (2019-2024)
Table 35. Global Neisseria meningitidis Infections Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Neisseria meningitidis Infections Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2019-2024)
Table 38. North America Neisseria meningitidis Infections Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neisseria meningitidis Infections Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neisseria meningitidis Infections Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neisseria meningitidis Infections Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Basic Information
Table 44. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Overview
Table 45. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Beijing Minhai Biotechnology Co Ltd Business Overview
Table 47. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug SWOT Analysis
Table 48. Beijing Minhai Biotechnology Co Ltd Recent Developments
Table 49. Biological E Ltd Neisseria meningitidis Infections Drug Basic Information
Table 50. Biological E Ltd Neisseria meningitidis Infections Drug Product Overview
Table 51. Biological E Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biological E Ltd Business Overview
Table 53. Biological E Ltd Neisseria meningitidis Infections Drug SWOT Analysis
Table 54. Biological E Ltd Recent Developments
Table 55. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Basic Information
Table 56. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Overview
Table 57. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug SWOT Analysis
Table 59. China National Pharmaceutical Group Corp Business Overview
Table 60. China National Pharmaceutical Group Corp Recent Developments
Table 61. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Basic Information
Table 62. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Overview
Table 63. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. GlaxoSmithKline Plc Business Overview
Table 65. GlaxoSmithKline Plc Recent Developments
Table 66. Griffith University Neisseria meningitidis Infections Drug Basic Information
Table 67. Griffith University Neisseria meningitidis Infections Drug Product Overview
Table 68. Griffith University Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Griffith University Business Overview
Table 70. Griffith University Recent Developments
Table 71. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Basic Information
Table 72. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Overview
Table 73. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. ImmunoBiology Ltd Business Overview
Table 75. ImmunoBiology Ltd Recent Developments
Table 76. JN-International Medical Corp Neisseria meningitidis Infections Drug Basic Information
Table 77. JN-International Medical Corp Neisseria meningitidis Infections Drug Product Overview
Table 78. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. JN-International Medical Corp Business Overview
Table 80. JN-International Medical Corp Recent Developments
Table 81. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Basic Information
Table 82. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Overview
Table 83. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. MGB Biopharma Ltd Business Overview
Table 85. MGB Biopharma Ltd Recent Developments
Table 86. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Basic Information
Table 87. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Overview
Table 88. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Panacea Biotec Ltd Business Overview
Table 90. Panacea Biotec Ltd Recent Developments
Table 91. Pfizer Inc Neisseria meningitidis Infections Drug Basic Information
Table 92. Pfizer Inc Neisseria meningitidis Infections Drug Product Overview
Table 93. Pfizer Inc Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Inc Business Overview
Table 95. Pfizer Inc Recent Developments
Table 96. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Basic Information
Table 97. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Overview
Table 98. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sanofi Pasteur SA Business Overview
Table 100. Sanofi Pasteur SA Recent Developments
Table 101. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Basic Information
Table 102. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Overview
Table 103. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Serum Institute of India Ltd Business Overview
Table 105. Serum Institute of India Ltd Recent Developments
Table 106. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Basic Information
Table 107. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Overview
Table 108. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Wellstat Vaccines LLC Business Overview
Table 110. Wellstat Vaccines LLC Recent Developments
Table 111. Global Neisseria meningitidis Infections Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Neisseria meningitidis Infections Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Neisseria meningitidis Infections Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Neisseria meningitidis Infections Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Neisseria meningitidis Infections Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Neisseria meningitidis Infections Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Neisseria meningitidis Infections Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Neisseria meningitidis Infections Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Neisseria meningitidis Infections Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Neisseria meningitidis Infections Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Neisseria meningitidis Infections Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Neisseria meningitidis Infections Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neisseria meningitidis Infections Drug Market Size Comparison by Region (M USD)
Table 5. Global Neisseria meningitidis Infections Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neisseria meningitidis Infections Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neisseria meningitidis Infections Drug as of 2022)
Table 10. Global Market Neisseria meningitidis Infections Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neisseria meningitidis Infections Drug Sales Sites and Area Served
Table 12. Manufacturers Neisseria meningitidis Infections Drug Product Type
Table 13. Global Neisseria meningitidis Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neisseria meningitidis Infections Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neisseria meningitidis Infections Drug Market Challenges
Table 22. Global Neisseria meningitidis Infections Drug Sales by Type (Kilotons)
Table 23. Global Neisseria meningitidis Infections Drug Market Size by Type (M USD)
Table 24. Global Neisseria meningitidis Infections Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2019-2024)
Table 26. Global Neisseria meningitidis Infections Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Neisseria meningitidis Infections Drug Market Size Share by Type (2019-2024)
Table 28. Global Neisseria meningitidis Infections Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neisseria meningitidis Infections Drug Sales (Kilotons) by Application
Table 30. Global Neisseria meningitidis Infections Drug Market Size by Application
Table 31. Global Neisseria meningitidis Infections Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2019-2024)
Table 33. Global Neisseria meningitidis Infections Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Neisseria meningitidis Infections Drug Market Share by Application (2019-2024)
Table 35. Global Neisseria meningitidis Infections Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Neisseria meningitidis Infections Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2019-2024)
Table 38. North America Neisseria meningitidis Infections Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neisseria meningitidis Infections Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neisseria meningitidis Infections Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neisseria meningitidis Infections Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Basic Information
Table 44. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Overview
Table 45. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Beijing Minhai Biotechnology Co Ltd Business Overview
Table 47. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug SWOT Analysis
Table 48. Beijing Minhai Biotechnology Co Ltd Recent Developments
Table 49. Biological E Ltd Neisseria meningitidis Infections Drug Basic Information
Table 50. Biological E Ltd Neisseria meningitidis Infections Drug Product Overview
Table 51. Biological E Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biological E Ltd Business Overview
Table 53. Biological E Ltd Neisseria meningitidis Infections Drug SWOT Analysis
Table 54. Biological E Ltd Recent Developments
Table 55. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Basic Information
Table 56. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Overview
Table 57. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug SWOT Analysis
Table 59. China National Pharmaceutical Group Corp Business Overview
Table 60. China National Pharmaceutical Group Corp Recent Developments
Table 61. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Basic Information
Table 62. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Overview
Table 63. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. GlaxoSmithKline Plc Business Overview
Table 65. GlaxoSmithKline Plc Recent Developments
Table 66. Griffith University Neisseria meningitidis Infections Drug Basic Information
Table 67. Griffith University Neisseria meningitidis Infections Drug Product Overview
Table 68. Griffith University Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Griffith University Business Overview
Table 70. Griffith University Recent Developments
Table 71. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Basic Information
Table 72. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Overview
Table 73. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. ImmunoBiology Ltd Business Overview
Table 75. ImmunoBiology Ltd Recent Developments
Table 76. JN-International Medical Corp Neisseria meningitidis Infections Drug Basic Information
Table 77. JN-International Medical Corp Neisseria meningitidis Infections Drug Product Overview
Table 78. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. JN-International Medical Corp Business Overview
Table 80. JN-International Medical Corp Recent Developments
Table 81. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Basic Information
Table 82. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Overview
Table 83. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. MGB Biopharma Ltd Business Overview
Table 85. MGB Biopharma Ltd Recent Developments
Table 86. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Basic Information
Table 87. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Overview
Table 88. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Panacea Biotec Ltd Business Overview
Table 90. Panacea Biotec Ltd Recent Developments
Table 91. Pfizer Inc Neisseria meningitidis Infections Drug Basic Information
Table 92. Pfizer Inc Neisseria meningitidis Infections Drug Product Overview
Table 93. Pfizer Inc Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Inc Business Overview
Table 95. Pfizer Inc Recent Developments
Table 96. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Basic Information
Table 97. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Overview
Table 98. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sanofi Pasteur SA Business Overview
Table 100. Sanofi Pasteur SA Recent Developments
Table 101. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Basic Information
Table 102. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Overview
Table 103. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Serum Institute of India Ltd Business Overview
Table 105. Serum Institute of India Ltd Recent Developments
Table 106. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Basic Information
Table 107. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Overview
Table 108. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Wellstat Vaccines LLC Business Overview
Table 110. Wellstat Vaccines LLC Recent Developments
Table 111. Global Neisseria meningitidis Infections Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Neisseria meningitidis Infections Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Neisseria meningitidis Infections Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Neisseria meningitidis Infections Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Neisseria meningitidis Infections Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Neisseria meningitidis Infections Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Neisseria meningitidis Infections Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Neisseria meningitidis Infections Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Neisseria meningitidis Infections Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Neisseria meningitidis Infections Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Neisseria meningitidis Infections Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Neisseria meningitidis Infections Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Neisseria meningitidis Infections Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neisseria meningitidis Infections Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neisseria meningitidis Infections Drug Market Size (M USD), 2019-2030
Figure 5. Global Neisseria meningitidis Infections Drug Market Size (M USD) (2019-2030)
Figure 6. Global Neisseria meningitidis Infections Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neisseria meningitidis Infections Drug Market Size by Country (M USD)
Figure 11. Neisseria meningitidis Infections Drug Sales Share by Manufacturers in 2023
Figure 12. Global Neisseria meningitidis Infections Drug Revenue Share by Manufacturers in 2023
Figure 13. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neisseria meningitidis Infections Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neisseria meningitidis Infections Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neisseria meningitidis Infections Drug Market Share by Type
Figure 18. Sales Market Share of Neisseria meningitidis Infections Drug by Type (2019-2024)
Figure 19. Sales Market Share of Neisseria meningitidis Infections Drug by Type in 2023
Figure 20. Market Size Share of Neisseria meningitidis Infections Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Neisseria meningitidis Infections Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neisseria meningitidis Infections Drug Market Share by Application
Figure 24. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Application in 2023
Figure 26. Global Neisseria meningitidis Infections Drug Market Share by Application (2019-2024)
Figure 27. Global Neisseria meningitidis Infections Drug Market Share by Application in 2023
Figure 28. Global Neisseria meningitidis Infections Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neisseria meningitidis Infections Drug Sales Market Share by Country in 2023
Figure 32. U.S. Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neisseria meningitidis Infections Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neisseria meningitidis Infections Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country in 2023
Figure 37. Germany Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neisseria meningitidis Infections Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region in 2023
Figure 44. China Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neisseria meningitidis Infections Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Neisseria meningitidis Infections Drug Sales Market Share by Country in 2023
Figure 51. Brazil Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neisseria meningitidis Infections Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neisseria meningitidis Infections Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neisseria meningitidis Infections Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neisseria meningitidis Infections Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Neisseria meningitidis Infections Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Neisseria meningitidis Infections Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neisseria meningitidis Infections Drug Market Size (M USD), 2019-2030
Figure 5. Global Neisseria meningitidis Infections Drug Market Size (M USD) (2019-2030)
Figure 6. Global Neisseria meningitidis Infections Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neisseria meningitidis Infections Drug Market Size by Country (M USD)
Figure 11. Neisseria meningitidis Infections Drug Sales Share by Manufacturers in 2023
Figure 12. Global Neisseria meningitidis Infections Drug Revenue Share by Manufacturers in 2023
Figure 13. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neisseria meningitidis Infections Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neisseria meningitidis Infections Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neisseria meningitidis Infections Drug Market Share by Type
Figure 18. Sales Market Share of Neisseria meningitidis Infections Drug by Type (2019-2024)
Figure 19. Sales Market Share of Neisseria meningitidis Infections Drug by Type in 2023
Figure 20. Market Size Share of Neisseria meningitidis Infections Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Neisseria meningitidis Infections Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neisseria meningitidis Infections Drug Market Share by Application
Figure 24. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Application in 2023
Figure 26. Global Neisseria meningitidis Infections Drug Market Share by Application (2019-2024)
Figure 27. Global Neisseria meningitidis Infections Drug Market Share by Application in 2023
Figure 28. Global Neisseria meningitidis Infections Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neisseria meningitidis Infections Drug Sales Market Share by Country in 2023
Figure 32. U.S. Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neisseria meningitidis Infections Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neisseria meningitidis Infections Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country in 2023
Figure 37. Germany Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neisseria meningitidis Infections Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region in 2023
Figure 44. China Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neisseria meningitidis Infections Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Neisseria meningitidis Infections Drug Sales Market Share by Country in 2023
Figure 51. Brazil Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neisseria meningitidis Infections Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neisseria meningitidis Infections Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neisseria meningitidis Infections Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neisseria meningitidis Infections Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Neisseria meningitidis Infections Drug Market Share Forecast by Application (2025-2030)
